15 Citations (Scopus)
8 Downloads (Pure)

Abstract

Real-time continuous glucose monitoring (rtCGM) and FreeStyle Libre glucose monitoring systems (isCGM) are new evolving technologies used in the management of Type 1 diabetes. They offer potential to improve diabetes control and reduce hypoglycaemia. rtCGM can be linked to insulin pump providing hybrid closed loop therapy. Families of children and young people are keen to have the benefit from these technologies. These are relatively expensive so it is important that health care professionals, families of children and young people (CYP) with diabetes are adequately trained in the use of these devices. Health care professionals need to be able to make patient selection based on individual needs and preferences to achieve maximum benefit. Association of Children's Diabetes Clinicians (ACDC) developed a comprehensive guideline in 2017 to help identify which patients may be most likely to benefit and how these technologies may be practically implemented. Since then new technologies have been introduced and the use of GCM has expanded in routine clinical practice. This article, aims to provide a practical approach and help identify which patients may be most likely to benefit and how the technology may be implemented in order to maximise the clinical benefits.

Original languageEnglish
Article number109196
Pages (from-to)1-9
Number of pages9
JournalDiabetes Research and Clinical Practice
Volume184
Early online date13 Jan 2022
DOIs
Publication statusPublished - 28 Feb 2022

Keywords

  • Children and young people
  • Continuous Glucose Monitoring
  • Technology
  • Time in range
  • Type 1 diabetes
  • Humans
  • Blood Glucose
  • Diabetes Mellitus, Type 1/drug therapy
  • Adolescent
  • Blood Glucose Self-Monitoring
  • Hypoglycemic Agents/therapeutic use
  • Insulin Infusion Systems
  • Child

Fingerprint

Dive into the research topics of 'A practical approach to continuous glucose monitoring (rtCGM) and FreeStyle Libre systems (isCGM) in children and young people with Type 1 diabetes'. Together they form a unique fingerprint.

Cite this